Skip to content

Study on the model and application of microwave ablation for glioma

Study on the model and application of microwave ablation for glioma

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037774
Enrollment
Unknown
Registered
2020-09-01
Start date
2021-02-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glioma

Interventions

Experimental group:Surgery and microwave ablation

Sponsors

Beijing Ditan hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The patients were diagnosed as gliomas by contrast-enhanced MRI before operation; 2. The maximum diameter of the lesions was more than 3cm; 3. There were no uncontrollable underlying diseases, such as hypertension, heart disease and diabetes mellitus; 4. liver and kidney function and coagulation function could tolerate surgical treatment; 5. there was no contraindication of contrast-enhanced ultrasound examination; 6. agreed to accept enhanced MRI examination after operation; 7. agreed to accept microwave after full notification Ablation assisted surgery was performed to remove the tumor.

Exclusion criteria

Exclusion criteria: 1. the patients had uncontrollable underlying diseases; 2. severe liver and kidney function and coagulation dysfunction; 3. they did not agree to receive postoperative enhanced MRI examination; 4. combined with other malignant tumors.

Design outcomes

Primary

MeasureTime frame
OS;

Secondary

MeasureTime frame
adverse effects;

Countries

China

Contacts

Public ContactZhao Wenpeng

Beijing Ditan Hospital, Capital Medical University

zwp215@163.com+86 18610622549

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026